| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cerus Corporation (CERS) has 11 insiders with recent SEC Form 4 filings, including 4 buys and 11 sells. CERS is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 5.45M | $14.70M | - | |
| COO | 1.66M | $4.47M | -16,667 | |
| CFO | 1.17M | $3.15M | - | |
| Other | 1.06M | $2.86M | - | |
| Other | 879.1K | $2.37M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2, 2024 | Benjamin Richard J71 | Chief Medical Officer | Sell | 21,605 | $2.50 | $54,012.50 | -4.7% | -33.0% | -45.8% | |
| May 13, 2024 | Shan Hua | Director | Buy | 2,500 | $1.99 | $4,974.75 | +8.4% | +2.0% | -34.5% | |
| May 10, 2024 | Nachtsheim Jami K | Director | Buy | 2,000 | $1.79 | $3,578.20 | +1.9% | +26.0% | -25.4% | |
| May 9, 2024 | Swisher Daniel N Jr49 | Director | Buy | 2,500 | $1.88 | $4,688.75 | +2.4% | +9.4% | -32.5% | |
| May 9, 2024 | Witney Frank | Director | Buy | 20,000 | $1.89 | $37,800.00 | +12.5% | +9.4% | -32.5% | |
| Mar 14, 2024 | Green Kevin Dennis71 | Chief Financial Officer | Sale+OE | 42,555 | $1.99 | $84,881.86 | -3.3% | -7.1% | -26.8% | |
| Mar 14, 2024 | Jensen Chrystal71 | Chief Legal Officer | Sale+OE | 35,284 | $2.02 | $71,106.93 | -3.4% | -7.1% | -26.8% | |
| Mar 14, 2024 | Jayaraman Vivek K67 | Chief Operating Officer | Sale+OE | 53,041 | $2.02 | $106,892.15 | -2.9% | -7.1% | -26.8% | |
| Mar 14, 2024 | Greenman William Mariner70 | President And CEO | Sale+OE | 125,926 | $2.04 | $256,377.20 | -1.9% | -7.1% | -26.8% | |
| Mar 14, 2024 | Corash Laurence M73 | Chief Scientific Officer | Sale+OE | 28,427 | $2.02 | $57,288.20 | -0.6% | -7.1% | -26.8% |